Key facts
- It has raised $140K; the latest was Seed Round ($140K) in Jan 2025.
- Notable investors include Right Side Capital Management, Forum Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for BioMedict
- ·The full record, as it builds
Funding rounds
No funding rounds for BioMedict are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioMedict
Developer of an AI-powered application designed to objectively measure pain using biometrics. The company's application automatically and continuously monitors pain using patient biometrics to get essential insights into the duration, type, and intensity of pain, helping healthcare facilities improve clinical outcomes.
- Sector
- Healthcare
- HQ
- Newark, DE, United States
- Founded
- 2024
- Website
- biomedict.com/
- Ownership
- Privately Held (backing)
BioMedict doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioMedict shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioMedict in its N-PORT filings yet. We sweep new filings monthly.